Brain Metastasis in Patients With Non-Small-Cell Lung Cancer and Epidermal Growth Factor Receptor Mutations

被引：36
|
作者：
Bhatt, Vijaya R. [1 ]
Kedia, Shiksha [2 ]
Kessinger, Anne [1 ]
Ganti, Apar K. [1 ,3 ]
机构：
[1] Univ Nebraska, Med Ctr, Omaha, NE 68198 USA
[2] Staten Isl Univ Hosp, Staten Isl, NY USA
[3] Vet Affairs Nebraska Western Iowa Hlth Care Syst, Omaha, NE USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 25期
关键词：
EGFR MUTATIONS; CLINICAL-RESPONSE; ERLOTINIB; ADENOCARCINOMA; PROGRESSION; THERAPY; SURVIVAL; TUMORS;
D O I：
10.1200/JCO.2013.49.8915
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3162 / 3164
页数：3
相关论文
共 50 条
  • [41] Limitations in the Use of Serum Epidermal Growth Factor Receptor Mutations as Prognostic Markers for Non-Small-Cell Lung Cancer
    Zhang, Yongjun
    Bao, Wenlong
    Li, Zhijun
    [J]. MEDICAL PRINCIPLES AND PRACTICE, 2015, 24 (05) : 486 - 490
  • [42] Gefitinib treatment in patients with postoperative recurrent non-small-cell lung cancer harboring epidermal growth factor receptor gene mutations
    Yuhei Yokoyama
    Makoto Sonobe
    Tetsu Yamada
    Masaaki Sato
    Toshi Menju
    Akihiro Aoyama
    Toshihiko Sato
    Fengshi Chen
    Mitsugu Omasa
    Hiroshi Date
    [J]. International Journal of Clinical Oncology, 2015, 20 : 1122 - 1129
  • [43] Advanced non-small-cell lung cancer with epidermal growth factor receptor mutations: current evidence and future perspectives
    Costanzo, Raffaele
    Montanino, Agnese
    Di Maio, Massimo
    Piccirillo, Maria Carmela
    Sandomenico, Claudia
    Giordano, Pasqualina
    Daniele, Gennaro
    Franco, Renato
    Perrone, Francesco
    Rocco, Gaetano
    Normanno, Nicola
    Morabito, Alessandro
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2013, 13 (10) : 1207 - 1218
  • [44] Clinical Outcomes in Patients with Non-Small-Cell Lung Cancer (NSCLC) Harboring Rare Epidermal Growth Factor Receptor (EGFR) Mutations
    Domingues, Pedro M.
    Montella, Tatiane
    Zukin, Mauro
    Baldotto, Clarissa
    Ferreira, Carlos
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S206 - S207
  • [45] Surrogate endpoints for overall survival in advanced non-small-cell lung cancer patients with mutations of the epidermal growth factor receptor gene
    Yoshino, Reiko
    Imai, Hisao
    Mori, Keita
    Takei, Kousuke
    Tomizawa, Mai
    Kaira, Kyoichi
    Yoshii, Akihiro
    Tomizawa, Yoshio
    Saito, Ryusei
    Yamada, Masanobu
    [J]. MOLECULAR AND CLINICAL ONCOLOGY, 2014, 2 (05) : 731 - 736
  • [46] Testing Epidermal Growth Factor Receptor Mutations in Patients With Non-Small-Cell Lung Cancer to Choose Chemotherapy: The Other Side of the Coin
    Garassino, Marina Chiara
    Marsoni, Silvia
    Floriani, Irene
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (28) : 3835 - 3837
  • [47] Gefitinib treatment in patients with postoperative recurrent non-small-cell lung cancer harboring epidermal growth factor receptor gene mutations
    Yokoyama, Yuhei
    Sonobe, Makoto
    Yamada, Tetsu
    Sato, Masaaki
    Menju, Toshi
    Aoyama, Akihiro
    Sato, Toshihiko
    Chen, Fengshi
    Omasa, Mitsugu
    Date, Hiroshi
    [J]. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2015, 20 (06) : 1122 - 1129
  • [48] Epidermal growth factor vaccine in non-small-cell lung cancer
    Gonzalez Marinello, Gisela M.
    Santos, Edgardo S.
    Raez, Luis E.
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2012, 12 (04) : 439 - 445
  • [49] Interstitial lung disease in patients with non-small-cell lung cancer treated with epidermal growth factor receptor inhibitors
    Masahiro Tsuboi
    Thierry Le Chevalier
    [J]. Medical Oncology, 2006, 23 : 161 - 170
  • [50] Interstitial lung disease in patients with non-small-cell lung cancer treated with epidermal growth factor receptor inhibitors
    Tsuboi, M
    Le Chevalier, T
    [J]. MEDICAL ONCOLOGY, 2006, 23 (02) : 161 - 170
12345